Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Aloop Therapeutics ApS
APS
Active
Advertising protection
CVR 43257498
Sundkrogsgade 21, 2100
København Ø
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2022 · 4 years old
6 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Aloop Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-3M
-6M
-8M
-11M
2022: -5M
-5M
2022
2023: -9M (-80% vs 2022)
-9M
-80%
2023
2024: -1M (+89% vs 2023)
-1M
+89%
2024
2025: 0M (+100% vs 2024)
0M
2025
EBITDA
DKK millions
0M
-4M
-7M
-11M
-15M
2022: -5M
-5M
2022
2023: -12M (-140% vs 2022)
-12M
-140%
2023
2024: -3M (+75% vs 2023)
-3M
+75%
2024
2025: 0M (+100% vs 2024)
0M
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
Gross profit
-274
-1.323
-9.058
-4.550
Staff expenses
-0
-1.437
-2.846
-816
EBITDA
-274
-2.760
-11.904
-5.366
Depreciation & amort.
-0
-0
-0
-0
EBIT
-274
-2.760
-11.904
-5.366
Net financials
404
857
380
-22
Profit before tax
130
-1.903
-11.524
-5.388
Tax
200
-608
-2.715
-1.219
Net profit
-70
-1.295
-8.809
-4.169
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
Total assets
30.839
30.814
34.250
13.442
Equity
30.657
30.727
32.022
10.831
Long-term debt
0
0
0
0
Short-term debt
182
87
2.228
2.611
Total debt
182
87
2.228
2.611
Financial ratios
5-year trend
EBITDA margin (of gross profit)
<−999 %
This company
2022
2025
Equity ratio
99,4 %
This company
38,2 %
Market median
This company
Market median
160% above market
2022
2025
Return on equity
-0,2 %
This company
18,4 %
Market median
This company
Market median
101% below market
2022
2025
Net profit margin (of gross profit)
<−999 %
This company
2022
2025
Asset turnover (of gross profit)
-0,01×
This company
2022
2025
Debt / equity
0,01×
This company
0,62×
Market median
This company
Market median
98% below market
2022
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-05-06 – 2022-12-31
View
PDF
More on Aloop Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
